Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism
Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alexander Schuh, Nikolaus Marx(RWTH Aachen University), Vincent Brandenburg(RWTH Aachen University), András Keszei(University of Toronto), Johannes Brachmann(Klinikum Coburg), Joerg Schroeder(University of Würzburg), Kinan Kneizeh(Universitätsklinikum Aachen), Timm Dirrichs, Leon J. Schurgers(Maastricht University), Jürgen Floege(Westfälische Hochschule), Claudia Göttsch(Universitätsklinikum Aachen), Dario Frank(Sankt-Antonius-Hospital Eschweiler), Sebastian Reinartz(Universitätsklinikum Aachen)
Cited by 6
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Cryptogenic Stroke and Underlying Atrial Fibrillation
|New England Journal of Medicine|2014|2.2k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure
|New England Journal of Medicine|2008|763
Spatial multi-omic map of human myocardial infarction
|Nature|2022|692